These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24115225)

  • 1. Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients.
    Buck M; Garcia-Tsao G; Groszmann RJ; Stalling C; Grace ND; Burroughs AK; Patch D; Matloff DS; Clopton P; Chojkier M
    Hepatology; 2014 Mar; 59(3):1052-9. PubMed ID: 24115225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
    Rincón D; Lo Iacono O; Tejedor M; Hernando A; Ripoll C; Catalina MV; Salcedo M; Matilla A; Senosiain M; Clemente G; Molinero LM; Albillos A; Bañares R
    Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.
    Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
    Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis.
    Bellis L; Nicodemo S; Galossi A; Guarisco R; Spilabotti L; Durola L; Dell'Unto O; Puoti C
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):273-7. PubMed ID: 17925921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.
    Manolakopoulos S; Triantos C; Theodoropoulos J; Vlachogiannakos J; Kougioumtzan A; Papatheodoridis G; Tzourmakliotis D; Karamanolis D; Burroughs AK; Archimandritis A; Raptis S; Avgerinos A
    J Hepatol; 2009 Sep; 51(3):468-74. PubMed ID: 19616339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
    J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes.
    Bruha R; Vitek L; Petrtyl J; Lenicek M; Urbanek P; Zelenka J; Jachymova M; Svestka T; Kalab M; Dousa M; Marecek Z
    Scand J Gastroenterol; 2006 Dec; 41(12):1454-63. PubMed ID: 17101577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels.
    Kondo M; Miszputen SJ; Leite-mor MM; Parise ER
    Hepatogastroenterology; 1995; 42(5):542-5. PubMed ID: 8751212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers.
    Hernández-Gea V; Aracil C; Colomo A; Garupera I; Poca M; Torras X; Miñana J; Guarner C; Villanueva C
    Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis.
    Qamar AA; Grace ND; Groszmann RJ; Garcia-Tsao G; Bosch J; Burroughs AK; Maurer R; Planas R; Escorsell A; Garcia-Pagan JC; Patch D; Matloff DS; Makuch R;
    Hepatology; 2008 Jan; 47(1):153-9. PubMed ID: 18161700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis.
    Reverter E; Blasi A; Abraldes JG; Martínez-Palli G; Seijo S; Turon F; Berzigotti A; Balust J; Bosch J; García-Pagán JC
    Liver Int; 2014 Jan; 34(1):16-25. PubMed ID: 23763484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.
    Groszmann RJ; Garcia-Tsao G; Bosch J; Grace ND; Burroughs AK; Planas R; Escorsell A; Garcia-Pagan JC; Patch D; Matloff DS; Gao H; Makuch R;
    N Engl J Med; 2005 Nov; 353(21):2254-61. PubMed ID: 16306522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of hepatic venous pressure gradient measurement in the prediction of stage 1 compensated liver cirrhosis in patients with chronic hepatitis B.
    Suk KT; Kim HC; Namkung S; Han SH; Choi KC; Park SH; Sung HT; Kim CH; Kim SH; Ham YL; Kang HM; Kim DJ
    Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1170-6. PubMed ID: 23603784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis.
    Albillos A; Bañares R; González M; Ripoll C; Gonzalez R; Catalina MV; Molinero LM
    Am J Gastroenterol; 2007 May; 102(5):1116-26. PubMed ID: 17391317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis.
    Kim MY; Suk KT; Baik SK; Kim HA; Kim YJ; Cha SH; Kwak HR; Cho MY; Park HJ; Jeon HK; Park SY; Kim BR; Hong JH; Jo KW; Kim JW; Kim HS; Kwon SO; Chang SJ; Baik GH; Kim DJ
    Hepatology; 2012 Sep; 56(3):1053-62. PubMed ID: 22473911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
    Robic MA; Procopet B; Métivier S; Péron JM; Selves J; Vinel JP; Bureau C
    J Hepatol; 2011 Nov; 55(5):1017-24. PubMed ID: 21354450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.